AzTrials
AzTrials

In Vitro FertilizationPhase 1TVUSETNCT00826332

Transvaginal vs Transabdominal Ultrasound Guided Embryo Transfer

A Phase 1 study testing transabdominal ultrasound and transvaginal ultrasound in people with In Vitro Fertilization, run by Hadassah Medical Organization at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Embryo transfer is the last step in the IVF process. it is now recognized that this step should be done carefully and that it affects success rates. in recent years, sonographic guidance appears to increase success rates. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
In Vitro Fertilization
What is being tested?
transabdominal ultrasound and transvaginal ultrasound
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteIsrael
Study dates
Jan 2009to Dec 2010
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • high quality embryos fro transfer

Who cannot join

  • repeated IVF failure

Trial locations and contacts

1 site in 1 country.

Israel1 site, 1 recruiting
  • Hadassah University Hospital

    Jerusalem, 91128

    Ariel Revel, MD, 97226776424, arielr2@hadassah.org.il

    Recruiting

Other trials in Israel

About this study

Official title: Transvaginal or Transabdominal Ultrasound Guided Embryo Transfer- Which is Better?

Embryo transfer is the last step in the IVF process. it is now recognized that this step should be done carefully and that it affects success rates. in recent years, sonographic guidance appears to increase success rates.

Read the detailed description

Embryo transfer is the last step in the IVF process. it involves the insertion of a soft catheter through the uterine cervix. It is now recognized that this step should be done carefully and that it affects success rates. The embyos should be carefully deposited in the cavity. special care should be given to avoid touching the uterine fundus during the procedure. In recent years, sonographic guidance appears to increase success rates.

Being tested
transabdominal ultrasound, transvaginal ultrasound
Keywords
ultrasound, IVF, Embryo transfer, Pregnancy rate, female patient undergoing IVF

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transabdominal ultrasoundProcedure or surgery

    transabdominal ultrasound

  • transvaginal ultrasoundProcedure or surgery

    transvaginal ultrasound

Study groups in NCT00826332
Study groupRoleWhat they receive
AbdominalActive comparatorTransabdominal ultrasound guided embryo transfer
Receives: Procedure: transabdominal ultrasound
VaginalActive comparatorTransvaginal ultrasound guided embryo transfer
Receives: Procedure: transvaginal ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pregnancy

    Measured: 14 days

Secondary outcomes (1)
  1. patient satisfaction

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2009 (estimated)
  2. Study startJan 2009
  3. Primary completionDec 2009 (estimated)
  4. Study completionDec 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00826332
Sponsor's protocol ID
0594-08-HMO-CTIL
Acronym
TVUSET
Status last verified
Jan 2009
First submitted
21 Jan 2009
Last updated
22 Jan 2009
Results posted
No
Data monitoring committee
Yes

Publications

  • Sallam HN, Sadek SS. Ultrasound-guided embryo transfer: a meta-analysis of randomized controlled trials. Fertil Steril. 2003 Oct;80(4):1042-6. doi: 10.1016/s0015-0282(03)01009-4.

    PubMed 14556831
  • Karavani G, Ben-Meir A, Shufaro Y, Hyman JH, Revel A. Transvaginal ultrasound to guide embryo transfer: a randomized controlled trial. Fertil Steril. 2017 May;107(5):1159-1165. doi: 10.1016/j.fertnstert.2017.01.023. Epub 2017 Mar 24.

    PubMed 28347493

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing transabdominal ultrasound and transvaginal ultrasound in people with In Vitro Fertilization, run by Hadassah Medical Organization at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Jan 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ariel Revel, MD (97226776424, arielr2@hadassah.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pregnancy (time frame: 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00826332, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in